Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial.
Liang J, E M, Wu G, Zhao L, Li X, Xiu X, Li N, Chen B, Hui Z, Lv J, Fang H, Tang Y, Bi N, Wang W, Zhai Y, Li T, Chen D, Zou S, Lu N, Perez-Rodríguez R, Zheng J, Wang L.
Liang J, et al. Among authors: e m.
Onco Targets Ther. 2013 Nov 6;6:1589-96. doi: 10.2147/OTT.S50945. eCollection 2013.
Onco Targets Ther. 2013.
PMID: 24235844
Free PMC article.